CASP3 and acute lymphoblastic leukemia: However, using enzyme assays we observed a transient increase in activity of both caspase-8 and caspase-3 in three B-ALL cell lines treated with MLN0128/vorinostat that was significantly higher than in cells treated with single agents (Fig. S4).